Stay updated on Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe Record History now shows a new revision entry v3.5.0 and removes the previous v3.4.3 entry.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.4.3 was added. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedOn 2026-02-12, 48 entries were added; on 2026-02-13, Contacts/Locations and Study Status sections were added. A deletion occurred on 2026-01-16.SummaryDifference0.3%

- Check53 days agoChange DetectedRevision: v3.4.2 was added to the history. The notices about government funding and the previous Revision: v3.4.1 entry were removed.SummaryDifference0.5%

- Check60 days agoChange DetectedA site-wide government funding notice was added and the page shows a new revision tag (v3.4.1) replacing the previous (v3.4.0).SummaryDifference0.5%

- Check67 days agoChange DetectedA 'Show glossary' option was added and explanations for color-coded changes were introduced on the history page. The revision note was updated to v3.4.0 and the previous v3.3.4 label was removed.SummaryDifference0.6%

Stay in the know with updates to Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.